{"hands_on_practices": [{"introduction": "This first practice focuses on a fundamental skill in pharmacotherapy: calculating a safe and effective drug regimen for a pediatric patient. Unlike in adults, pediatric dosing relies heavily on weight-based calculations to ensure efficacy while preventing toxicity. This exercise [@problem_id:4751639] will guide you through determining an appropriate dose and the minimum safe dosing interval for ibuprofen, reinforcing the critical link between a single dose, the total daily exposure, and the timing of administration.", "problem": "A pediatric patient in a stomatology clinic presents with acute postoperative dental pain requiring an analgesic regimen. The clinician selects ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), for its combined analgesic and anti-inflammatory effects. The patient weighs $24\\ \\text{kg}$. The clinician aims to use a weight-based dosing approach commonly supported by pediatric pharmacology, adhering to two fundamental principles:\n\n1. Weight-based dose per administration is defined as $d = w \\times m$, where $w$ is the per-kilogram dose and $m$ is body mass.\n2. The maximum total daily exposure is constrained by $D_{\\max} = W \\times m$, where $W$ is the maximum daily exposure per kilogram.\n\nFor ibuprofen in this context, take the per-dose weight-based target as $w = 10\\ \\text{mg/kg}$ and the maximum daily exposure as $W = 40\\ \\text{mg/kg/day}$. The clinician plans a fixed-interval schedule over a $24$-hour period with evenly spaced administrations, each of equal dose amount $d$, such that the total amount administered in $24$ hours does not exceed $D_{\\max}$.\n\nUsing only the definitions above and the constraint of an equal-interval $24$-hour schedule, determine the minimum permissible fixed dosing interval (in hours) that satisfies these constraints for this $24\\ \\text{kg}$ child. Express your final answer as a single number in hours. Do not include units in your final boxed answer.", "solution": "The problem requires the determination of the minimum permissible fixed dosing interval, which we will denote as $\\Delta t_{\\text{min}}$, for an ibuprofen regimen administered to a pediatric patient. The solution is derived by strictly following the provided definitions and constraints.\n\nLet the patient's body mass be $m$. From the problem statement, we are given $m = 24\\ \\text{kg}$.\nLet the per-kilogram dose for a single administration be $w$. We are given $w = 10\\ \\text{mg/kg}$.\nLet the maximum daily exposure per kilogram be $W$. We are given $W = 40\\ \\text{mg/kg/day}$.\nThe total time period for the dosing schedule is $T = 24\\ \\text{hours}$.\n\nThe first step is to calculate the dose amount for a single administration, denoted by $d$. The problem defines this using the formula $d = w \\times m$. By substituting the given values, we calculate $d$:\n$$d = (10\\ \\text{mg/kg}) \\times (24\\ \\text{kg}) = 240\\ \\text{mg}$$\nThus, each dose administered to the patient will be $240\\ \\text{mg}$ of ibuprofen.\n\nThe second step is to calculate the maximum total dose that can be administered over a $24$-hour period, a quantity denoted by $D_{\\max}$. The problem defines this as $D_{\\max} = W \\times m$. Substituting the given values:\n$$D_{\\max} = (40\\ \\text{mg/kg/day}) \\times (24\\ \\text{kg}) = 960\\ \\text{mg/day}$$\nThis means the total amount of ibuprofen administered over a $24$-hour period must not exceed $960\\ \\text{mg}$.\n\nThe regimen consists of $N$ administrations of an equal dose amount $d$ on a fixed-interval schedule over the period $T = 24\\ \\text{hours}$. The total amount of drug administered is the product $N \\times d$. The principal constraint is that this total amount must not exceed the maximum daily exposure, $D_{\\max}$. This is expressed by the inequality:\n$$N \\times d \\leq D_{\\max}$$\n\nTo determine the maximum number of doses, $N_{\\max}$, that can be administered in compliance with this constraint, we rearrange the inequality to solve for $N$:\n$$N \\leq \\frac{D_{\\max}}{d}$$\nWe can compute the ratio $\\frac{D_{\\max}}{d}$ either from the calculated values of $d$ and $D_{\\max}$, or more fundamentally from their definitions:\n$$\\frac{D_{\\max}}{d} = \\frac{W \\times m}{w \\times m} = \\frac{W}{w}$$\nSubstituting the per-kilogram parameters $W$ and $w$:\n$$\\frac{W}{w} = \\frac{40\\ \\text{mg/kg/day}}{10\\ \\text{mg/kg}} = 4$$\nThe inequality simplifies to $N \\leq 4$. Since the number of administrations $N$ must be a positive integer, the maximum number of doses that can be given in a $24$-hour period is $N_{\\max} = 4$.\n\nThe final step is to determine the minimum permissible fixed dosing interval, $\\Delta t_{\\text{min}}$. The administrations are to be evenly spaced over the total period $T = 24\\ \\text{hours}$. The interval between consecutive doses, $\\Delta t$, is the total time period divided by the number of doses:\n$$\\Delta t = \\frac{T}{N}$$\nTo find the minimum possible interval, $\\Delta t_{\\text{min}}$, we must use the maximum possible number of administrations, $N_{\\max}$. A greater number of doses within the same time period necessarily corresponds to a shorter interval between them.\n$$\\Delta t_{\\text{min}} = \\frac{T}{N_{\\max}}$$\n\nSubstituting the values $T = 24\\ \\text{hours}$ and $N_{\\max} = 4$:\n$$\\Delta t_{\\text{min}} = \\frac{24\\ \\text{hours}}{4} = 6\\ \\text{hours}$$\n\nTherefore, the minimum permissible fixed dosing interval for this patient is $6$ hours. This regimen corresponds to administering a dose of $240\\ \\text{mg}$ every $6$ hours, resulting in a total daily dose of $4 \\times 240\\ \\text{mg} = 960\\ \\text{mg}$, which exactly equals the maximum allowed daily exposure $D_{\\max}$ and thus satisfies all the specified conditions.", "answer": "$$\\boxed{6}$$", "id": "4751639"}, {"introduction": "Moving beyond simple dosing, this practice explores the long-term pharmacodynamic consequences of an irreversible inhibitor, aspirin. Because aspirin permanently disables the COX-1 enzyme in anucleated platelets, recovery of hemostatic function depends entirely on the body's natural platelet turnover rate. This exercise [@problem_id:4751608] challenges you to model this physiological recovery process from first principles, a vital skill for assessing bleeding risk and timing elective dental surgery in patients on antiplatelet therapy.", "problem": "A patient scheduled for uncomplicated single-tooth extraction has been taking low-dose acetylsalicylic acid (aspirin), a non-steroidal anti-inflammatory drug (NSAID), for secondary cardiovascular prevention. Aspirin irreversibly acetylates platelet cyclooxygenase-1 (COX-1), abolishing thromboxane A$_2$ synthesis and thereby impairing primary hemostasis for the lifespan of affected platelets. Platelets are anucleate and do not resynthesize COX-1; recovery of function depends on the appearance of newly formed, uninhibited platelets from the bone marrow.\n\nAssume the following idealized conditions grounded in standard hematologic pharmacology:\n- At time $t=0$ (the moment aspirin is stopped), essentially all circulating platelets are inhibited with respect to COX-1–dependent aggregation.\n- The total circulating platelet pool size remains constant.\n- Platelet turnover follows steady-state replacement in which a constant fraction $r$ of the circulating platelet pool is newly produced per day. Take $r=0.10$ (that is, $10\\%$ daily replacement), consistent with an average platelet lifespan of approximately $10$ days.\n- Newly produced platelets are fully functional (uninhibited), and previously inhibited platelets do not regain function.\n- There is no further aspirin exposure after $t=0$ and no differential sequestration or destruction of inhibited versus uninhibited platelets.\n\nStarting from these premises and without invoking unproven shortcut formulas, derive from first principles an expression for the fraction of the circulating platelet pool with intact COX-1–mediated function $F(n)$ after $n$ days off aspirin, and then compute the value for $n=5$ days. Based on the magnitude of $F(5)$, briefly discuss whether primary hemostatic function is substantially restored for a low-risk dental extraction using local hemostatic measures, but report only the numerical value of $F(5)$ as your final answer.\n\nExpress the final value of $F(5)$ as a decimal fraction with no units and round to four significant figures.", "solution": "The problem is scientifically grounded, well-posed, objective, and internally consistent. It is based on established principles of pharmacology and hematology, specifically the irreversible inhibition of platelet COX-1 by acetylsalicylic acid and the kinetics of platelet turnover. The provided assumptions represent a standard, idealized model for this biological process, allowing for a rigorous mathematical derivation. The problem is therefore valid and a solution can be derived from first principles as requested.\n\nLet $F(n)$ be the fraction of the circulating platelet pool with intact cyclooxygenase-1 (COX-1) mediated function after $n$ days off aspirin. Correspondingly, let $I(n)$ be the fraction of the platelet pool that remains inhibited. Since the total platelet pool is composed entirely of functional and inhibited platelets, we have the relation:\n$$F(n) + I(n) = 1$$\nThe problem states that at time $t=0$ (which we define as the end of day $n=0$), essentially all circulating platelets are inhibited. This provides the initial condition:\n$$I(0) = 1 \\implies F(0) = 0$$\nWe are given that a constant fraction $r$ of the circulating platelet pool is newly produced each day. These new platelets are fully functional. The same fraction $r$ of the existing platelet pool is removed, without preference for inhibited or uninhibited platelets.\n\nLet us model the change in the fraction of inhibited platelets, $I(n)$, from day $n$ to day $n+1$. The number of inhibited platelets at the end of day $n$ is proportional to $I(n)$. During day $n+1$, a fraction $r$ of these inhibited platelets are removed from circulation. Since the newly produced platelets are all functional, no new inhibited platelets are added to the pool.\nTherefore, the fraction of inhibited platelets at the end of day $n+1$ is the fraction from the previous day, reduced by the fraction that was removed:\n$$I(n+1) = I(n) - r \\cdot I(n)$$\n$$I(n+1) = (1-r) I(n)$$\nThis is a first-order linear recurrence relation. We can solve it by iteration, starting from the initial condition $I(0) = 1$:\n$$I(1) = (1-r) I(0) = 1-r$$\n$$I(2) = (1-r) I(1) = (1-r)^2$$\nBy induction, the general solution for the fraction of inhibited platelets after $n$ days is:\n$$I(n) = (1-r)^n$$\nNow, we can derive the expression for the fraction of functional platelets, $F(n)$, using the relationship $F(n) = 1 - I(n)$. Substituting the expression for $I(n)$, we obtain:\n$$F(n) = 1 - (1-r)^n$$\nThis equation represents the fraction of the circulating platelet pool with intact COX-1 function after $n$ days off aspirin, derived from the stated first principles.\n\nThe problem requires the computation of this value for $n=5$ days, given a daily platelet replacement rate of $r = 0.10$.\nSubstituting these values into our derived expression:\n$$F(5) = 1 - (1 - 0.10)^5$$\n$$F(5) = 1 - (0.90)^5$$\nWe calculate the value of $(0.90)^5$:\n$$(0.90)^5 = 0.90 \\times 0.90 \\times 0.90 \\times 0.90 \\times 0.90 = 0.59049$$\nSubstituting this result back into the equation for $F(5)$:\n$$F(5) = 1 - 0.59049 = 0.40951$$\nThe problem asks for this value to be rounded to four significant figures. The fifth significant figure is $1$, so we round down.\n$$F(5) \\approx 0.4095$$\nThis result indicates that after $5$ days off aspirin, approximately $41\\%$ of the patient's platelets are functional. For minor surgical procedures such as an uncomplicated single-tooth extraction, a functional platelet level of $30\\%-50\\%$ is often considered adequate to achieve primary hemostasis, provided that effective local hemostatic measures are employed. Thus, a value of $F(5) \\approx 0.41$ suggests that hemostatic function is substantially, though not completely, restored.", "answer": "$$\\boxed{0.4095}$$", "id": "4751608"}, {"introduction": "This final practice integrates pharmacological principles into a complex clinical scenario, reflecting the realities of patient care. Analgesic selection must account for a patient's underlying conditions and concurrent medications, as interactions can lead to serious adverse events. This case study [@problem_id:4751669] requires you to apply your knowledge of renal physiology and drug mechanisms to diagnose and manage NSAID-induced acute kidney injury, demonstrating the critical thinking required to ensure patient safety in a real-world context.", "problem": "A $56\\ \\text{year}$-old man undergoes surgical extraction of an impacted mandibular third molar. Postoperatively, he is prescribed non-steroidal anti-inflammatory drugs (NSAIDs), specifically ibuprofen $600\\ \\text{mg}$ every $8\\ \\text{h}$, for analgesia. Baseline preoperative laboratory testing showed a serum creatinine of $1.0\\ \\text{mg/dL}$. After $48\\ \\text{h}$ of NSAID therapy, repeat testing shows a serum creatinine of $1.4\\ \\text{mg/dL}$. He reports decreased oral intake, mild lightheadedness on standing, and reduced urine output. His chronic medications include lisinopril $20\\ \\text{mg/day}$ and hydrochlorothiazide $25\\ \\text{mg/day}$ for hypertension. He denies rash, fever, flank pain, or gross hematuria.\n\nUsing first principles, interpret the pathophysiological mechanism underlying the creatinine change in the context of analgesic pharmacology and renal physiology, and select the most appropriate management plan within stomatologic care. Base your reasoning on the following well-tested facts and definitions:\n\n- Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX), reducing renal prostaglandin synthesis.\n- Renal prostaglandins normally support afferent arteriolar dilation, helping maintain glomerular filtration rate (GFR) under conditions of reduced effective circulating volume.\n- Glomerular filtration rate is determined by the net filtration pressure across the glomerular capillary, classically expressed as $$\\text{GFR} = K_f \\left(P_{GC} - P_{BS} - \\pi_{GC}\\right),$$ where $K_f$ is the ultrafiltration coefficient, $P_{GC}$ is glomerular capillary hydrostatic pressure, $P_{BS}$ is Bowman's space hydrostatic pressure, and $\\pi_{GC}$ is glomerular capillary oncotic pressure.\n- Kidney Disease: Improving Global Outcomes (KDIGO) defines acute kidney injury (AKI) as an increase in serum creatinine by $\\ge 0.3\\ \\text{mg/dL}$ within $48\\ \\text{h}$ or to $\\ge 1.5$ times baseline within $7\\ \\text{days}$.\n\nWhich option best integrates the correct interpretation and an appropriate management plan?\n\nA. NSAID-induced, hemodynamically mediated acute kidney injury (AKI) due to prostaglandin inhibition causing afferent arteriolar constriction and reduced $P_{GC}$; immediately discontinue NSAIDs, correct volume depletion, switch analgesia to acetaminophen with a conservative maximum of $\\le 3.0\\ \\text{g/day}$ and consider short-course rescue opioid or local anesthetic measures if needed; temporarily hold angiotensin-converting enzyme inhibitor (ACEI) and diuretic if clinically appropriate; recheck creatinine and electrolytes in $48$–$72\\ \\text{h}$.\n\nB. Normal biological variability in creatinine; continue ibuprofen and add a proton pump inhibitor to protect renal function; recheck labs in $2\\ \\text{weeks}$.\n\nC. Acute interstitial nephritis (AIN) is likely; initiate systemic corticosteroids while continuing NSAIDs to control pain, and monitor.\n\nD. Switch to a selective cyclooxygenase-2 (COX-2) inhibitor (for example, celecoxib) to avoid renal effects of NSAIDs; continue therapy at equivalent analgesic dosing.\n\nE. Continue NSAIDs but increase oral fluid intake; avoid laboratory re-evaluation unless symptoms worsen, as the rise from $1.0$ to $1.4\\ \\text{mg/dL}$ is below the $1.5$ times threshold for AKI.", "solution": "The problem statement is evaluated for validity before proceeding to a solution.\n\n### Step 1: Extract Givens\n- Patient: $56\\ \\text{year}$-old man\n- Procedure: Surgical extraction of impacted mandibular third molar\n- Postoperative medication: Ibuprofen $600\\ \\text{mg}$ every $8\\ \\text{h}$\n- Baseline serum creatinine: $1.0\\ \\text{mg/dL}$\n- Follow-up serum creatinine after $48\\ \\text{h}$: $1.4\\ \\text{mg/dL}$\n- Symptoms: Decreased oral intake, mild lightheadedness on standing, reduced urine output\n- Chronic medications: Lisinopril $20\\ \\text{mg/day}$, hydrochlorothiazide $25\\ \\text{mg/day}$\n- Negative findings: No rash, fever, flank pain, or gross hematuria\n- Given Principle 1: Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX), reducing renal prostaglandin synthesis.\n- Given Principle 2: Renal prostaglandins normally support afferent arteriolar dilation, helping maintain glomerular filtration rate (GFR) under conditions of reduced effective circulating volume.\n- Given Principle 3: Glomerular filtration rate is defined by the equation $\\text{GFR} = K_f \\left(P_{GC} - P_{BS} - \\pi_{GC}\\right)$, where $K_f$ is the ultrafiltration coefficient, $P_{GC}$ is glomerular capillary hydrostatic pressure, $P_{BS}$ is Bowman's space hydrostatic pressure, and $\\pi_{GC}$ is glomerular capillary oncotic pressure.\n- Given Principle 4: Kidney Disease: Improving Global Outcomes (KDIGO) defines acute kidney injury (AKI) as an increase in serum creatinine by $\\ge 0.3\\ \\text{mg/dL}$ within $48\\ \\text{h}$ or to $\\ge 1.5$ times baseline within $7\\ \\text{days}$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, well-posed, and objective.\n- **Scientific Grounding:** The scenario is a classic and well-documented clinical presentation of drug-induced kidney injury. The principles provided—the role of NSAIDs and prostaglandins in renal hemodynamics, the Starling equation for glomerular filtration, and the KDIGO definition of AKI—are all fundamental and accurate concepts in physiology, pharmacology, and nephrology.\n- **Well-Posedness:** The problem provides all necessary data (patient history, medications, symptoms, lab values, timeline) to allow for a rigorous pathophysiological interpretation and the formulation of a management plan based on established medical principles.\n- **Objectivity and Consistency:** The information is presented factually and quantitatively. The patient's chronic medications (an ACE inhibitor and a diuretic) and postoperative state (decreased oral intake) create a coherent clinical picture that is consistent with the observed change in renal function after the introduction of an NSAID.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. A solution can be derived.\n\n### Pathophysiological Interpretation and Derivation\n\n1.  **Diagnosis of Acute Kidney Injury (AKI):**\n    The patient's baseline serum creatinine was $1.0\\ \\text{mg/dL}$. After $48\\ \\text{h}$, it increased to $1.4\\ \\text{mg/dL}$. The absolute increase is $1.4\\ \\text{mg/dL} - 1.0\\ \\text{mg/dL} = 0.4\\ \\text{mg/dL}$.\n    According to the provided KDIGO definition, AKI is diagnosed if serum creatinine increases by $\\ge 0.3\\ \\text{mg/dL}$ within $48\\ \\text{h}$. Since the patient's creatinine increased by $0.4\\ \\text{mg/dL}$ in $48\\ \\text{h}$, the diagnosis of AKI is established.\n\n2.  **Elucidation of the Mechanism (Hemodynamic AKI):**\n    The GFR is determined by the net filtration pressure, with glomerular capillary hydrostatic pressure ($P_{GC}$) being the primary driving force: $\\text{GFR} \\propto P_{GC}$. The value of $P_{GC}$ is regulated by the relative tones of the afferent (inflow) and efferent (outflow) arterioles of the glomerulus.\n    \n    The patient's clinical state involves three key factors that disrupt this regulation:\n    - **Volume Depletion:** The patient has decreased oral intake, reduced urine output, and lightheadedness on standing (orthostasis), all signs of reduced effective circulating volume. This state is exacerbated by his chronic use of a diuretic (hydrochlorothiazide). In response to volume depletion, the body activates compensatory mechanisms to preserve GFR.\n    - **NSAID Administration (Ibuprofen):** As stated, NSAIDs inhibit the synthesis of renal prostaglandins. In a volume-depleted state, prostaglandins are crucial for dilating the afferent arteriole to maintain blood flow into the glomerulus. By inhibiting prostaglandins, ibuprofen causes afferent arteriolar vasoconstriction, which reduces blood flow into the glomerulus and thereby decreases $P_{GC}$.\n    - **ACE Inhibitor Use (Lisinopril):** ACE inhibitors block the production of angiotensin II. A key function of angiotensin II in the kidney, especially during volume depletion, is to constrict the efferent arteriole. This efferent constriction increases the \"back-pressure\" within the glomerulus, thus raising $P_{GC}$ and preserving GFR. By blocking this effect, lisinopril causes efferent arteriolar vasodilation, which lowers $P_{GC}$.\n\n    This combination of an NSAID, an ACE inhibitor, and a diuretic in a volume-depleted patient is a well-known cause of AKI, often termed the \"triple whammy\". The NSAID constricts the afferent arteriole while the ACE inhibitor dilates the efferent arteriole. Both actions synergistically and profoundly decrease the glomerular capillary hydrostatic pressure ($P_{GC}$). According to the GFR equation, this fall in $P_{GC}$ leads to a sharp decline in GFR, causing the retention of waste products like creatinine and resulting in AKI. This is a purely functional, hemodynamic form of renal injury. The absence of rash, fever, or flank pain makes an allergic process like acute interstitial nephritis (AIN) much less likely.\n\n3.  **Appropriate Management Plan:**\n    The management must directly address the identified pathophysiology.\n    - **Remove Offending Agents:** The primary precipitant is the ibuprofen, which must be discontinued immediately. The other contributing agents, lisinopril and hydrochlorothiazide, should also be temporarily held until renal function recovers.\n    - **Restore Perfusion:** The underlying state of volume depletion must be corrected via increased oral or, if necessary, intravenous fluid administration.\n    - **Alternative Analgesia:** The patient still requires pain management. Acetaminophen is the appropriate first-line alternative as it lacks the renal hemodynamic effects of NSAIDs. Due to potential hepatic stress in an acutely ill patient with poor intake, a conservative maximum daily dose (e.g., $\\le 3.0\\ \\text{g/day}$) is prudent. For severe pain, non-pharmacologic methods, enhanced local anesthesia, or a short course of opioid analgesics may be considered.\n    - **Monitoring:** The patient must be monitored to ensure the AKI resolves. Rechecking serum creatinine and electrolytes in $48$–$72\\ \\text{h}$ is standard practice.\n\n### Evaluation of Options\n\n**A. NSAID-induced, hemodynamically mediated acute kidney injury (AKI) due to prostaglandin inhibition causing afferent arteriolar constriction and reduced $P_{GC}$; immediately discontinue NSAIDs, correct volume depletion, switch analgesia to acetaminophen with a conservative maximum of $\\le 3.0\\ \\text{g/day}$ and consider short-course rescue opioid or local anesthetic measures if needed; temporarily hold angiotensin-converting enzyme inhibitor (ACEI) and diuretic if clinically appropriate; recheck creatinine and electrolytes in $48$–$72\\ \\text{h}$.**\nThis option provides a precisely correct pathophysiological interpretation, identifying the hemodynamic nature of the AKI, the role of prostaglandins, afferent constriction, and the effect on $P_{GC}$. The proposed management plan is comprehensive, safe, and entirely consistent with best practices: it removes all offending agents, addresses the volume status, provides appropriate alternative analgesia with a sensible dose cap, and includes necessary follow-up.\n**Verdict: Correct.**\n\n**B. Normal biological variability in creatinine; continue ibuprofen and add a proton pump inhibitor to protect renal function; recheck labs in $2\\ \\text{weeks}$.**\nThis option is incorrect on multiple grounds. The creatinine rise of $0.4\\ \\text{mg/dL}$ in $48\\ \\text{h}$ is clinically significant and meets the formal criteria for AKI; it is not \"normal variability\". Continuing the offending drug (ibuprofen) is dangerous. Proton pump inhibitors protect the stomach, not the kidney, from NSAIDs; they have no role in managing this type of injury. Delaying follow-up for $2\\ \\text{weeks}$ would constitute negligent care.\n**Verdict: Incorrect.**\n\n**C. Acute interstitial nephritis (AIN) is likely; initiate systemic corticosteroids while continuing NSAIDs to control pain, and monitor.**\nThis option proposes the wrong diagnosis. The clinical picture (rapid onset, hemodynamic risk factors, absence of systemic allergic signs like rash or fever) strongly points away from AIN and towards hemodynamic AKI. The management is also incorrect; the offending drug should always be stopped, and corticosteroids are not indicated for this mechanism of injury.\n**Verdict: Incorrect.**\n\n**D. Switch to a selective cyclooxygenase-2 (COX-2) inhibitor (for example, celecoxib) to avoid renal effects of NSAIDs; continue therapy at equivalent analgesic dosing.**\nThis option is based on a false premise. Selective COX-2 inhibitors are not \"renally-sparing\". The COX-2 enzyme is constitutively expressed in the kidney and is upregulated in states of volume depletion, where it plays a critical role in synthesizing the prostaglandins that maintain renal blood flow. Switching to a COX-2 inhibitor would carry the same risk of hemodynamic AKI in this patient.\n**Verdict: Incorrect.**\n\n**E. Continue NSAIDs but increase oral fluid intake; avoid laboratory re-evaluation unless symptoms worsen, as the rise from $1.0$ to $1.4\\ \\text{mg/dL}$ is below the $1.5$ times threshold for AKI.**\nThis option incorrectly interprets the diagnostic criteria for AKI. The patient meets the criterion of an absolute increase of $\\ge 0.3\\ \\text{mg/dL}$ within $48\\ \\text{h}$. The diagnosis is established, and it is wrong to dismiss it. While increasing fluid intake is appropriate, continuing the causative agent (NSAID) and failing to monitor the established AKI is improper management.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4751669"}]}